Skip to main content
. Author manuscript; available in PMC: 2012 Apr 15.
Published in final edited form as: Biochem J. 2011 Apr 15;435(2):327–336. doi: 10.1042/BJ20102118

Table 1. Effects of FAAHI on DEA production by E18 hippocampal homogenates.

E18 hippocampi were homogenized and incubated with 5 µM [13C22]DHA for 1.5 h in the presence or absence of 1 µM URB597 (FAAHI), and the DEA and [13C22]DEA levels were determined by MS/MS as shown in Figure 4. DEA was produced from the endogenous DHA. The data are expressed as fmol/E18 hippocampus and are representative of triplicate experiments that were repeated three times.

DEA production (fmol/E18 hippocampus)

Treatment DEA [13C22]DEA
−FAAHI 12 ± 0.8 166 ± 20.0
+FAAHI 15 ± 1.1* 399 ± 39.5**
*

P < 0.05 and **P < 0.01 compared with the −FAAHI group for the DEA or [13C22]DEA production.